SARAH JULES: Open Payments
NPI 1215709928 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,335 in 127 payments from 17 companies in 2025. Trend: 2023 $79 · 2024 $1,844 · 2025 $3,335
Food & beverage: $3,238Education: $96
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $788 |
| GlaxoSmithKline, LLC. | 27 | $644 |
| United Therapeutics Corporation | 9 | $271 |
| Grifols USA, LLC | 15 | $264 |
| Verona Pharma, Inc. | 12 | $221 |
| Insmed, Inc. | 14 | $210 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $200 |
| Regeneron Healthcare Solutions, Inc. | 6 | $166 |
| Actelion Pharmaceuticals US, Inc. | 3 | $165 |
| HARMONY BIOSCIENCES LLC | 2 | $89 |
Products named: NUCALA, BREZTRI, DUPIXENT, Prolastin-C Liquid, Ohtuvayre, FASENRA, OFEV, Arikayce.
Industry payments across FL — which companies pay providers there.
